Company Overview and News
Bucking an overall weak broader market trend, defence stocks were in focus today, rising by up to 6 per cent, after the new Defence Procurement Procedure (DPP), focusing on India-made products and fast-tracked acquisition process, was cleared.
Late bounce back helped the market close higher for third consecutive session on Tuesday, majorly supported by index heavyweights Reliance Industries, HDFC and HDFC Bank. Cut in European markets' losses after pricing in Brussels blast also boosted sentiment.
Defence-related stocks such as Reliance Defence, Walchandnagar, Larsen and Toubro, BEML and BEL gained upto 10 per cent in early trade on Tuesday after the new Defence Procurement Procedure (DPP), focusing on India-made products and fast-tracked acquisition process, was cleared by the top committee of the Defence Ministry on Monday.
Domestic equity indices BSE Sensex and NSE Nifty are likely to open on a flat note on Tuesday tracking mixed global cues. Sensex on Monday gained for the second straight session and soared 333 points to close at 25,285. The 50-share Nifty recaptured the 7,700-mark and ended at 7,704.25, up 99.90 points, or 1.31 per cent.
Domestic equity indices BSE Sensex and NSE Nifty are likely to open on a flat note with positive bias on Tuesday tracking Nifty futures on the Singapore Stock Exchange (SGX Nifty) and mixed global cues.
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.
NEW DELHI, March 8 — India’s congested cities are awarding new rail projects at a record rate, creating a boon for companies such as Siemens to Larsen & Toubro Ltd in a sector forecast to offer US$5.8 billion (RM23.7 billion) worth of orders next
RH Muralidhara has been appointed as Director -Defence Business and Member of the Boar
The company has bagged the prestigious order valued at Rs. 900 crore for the supply of Metro Coaches to Kolkata East-West Metro Line.
The company has bagged an order worth of Rs 900 crore for supply of metro coaches to Kolkata east-west metro line...
BEML | Axis Bank | Vedanta | Lupin | CMI | Jaiprakash Associates | Sadbhav Infra | Sadbhav Engineering and IOC are stocks, which are in the news today...
And the winner is…no, we are not talking of the Oscars but of people who steal the show on the D-Street. Gurumurthy K and Yoganand D sound out traders who bet on previous Budgets and are gearing up for B-Day
Railway Budget 2016: The Railway Budget failed to lift most of the stocks of its leading vendors. Key rail wagon makers such as Kalindee Rail Nirman Engineers, Titagarh Wagons and Texmaco Rail Engineering fell between 8.5% and 9.5%.
Companies directly related to fortunes of railways got a beating on the bourses after
HDFC, Sun Pharma, ONGC, Coal India and Hindalco are top gainers, up 1-2 percent while Infosys, TCS, ICICI Bank and Reliance Industries declined 0.5-1 percent...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...